Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05939700
Mavacamten Pregnancy Surveillance Program
Sponsor: Bristol-Myers Squibb
View on ClinicalTrials.gov
Summary
The purpose of this observational pregnancy safety study is to assess maternal, fetal, and infant outcomes after exposure to mavacamten at any time during pregnancy and/or breastfeeding.
Key Details
Gender
FEMALE
Age Range
15 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2023-11-09
Completion Date
2027-04-30
Last Updated
2025-11-06
Healthy Volunteers
Not specified
Interventions
DRUG
Mavacamten
Observational study of individuals exposed to at least 1 dose of mavacamten at any time during pregnancy and/or breastfeeding
Locations (1)
The Mavacamten Pregnancy Surveillance Program, PPD Inc
Wilmington, North Carolina, United States